Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Kent

Showing results (91-100 of 390) with videos related to

Pageof 39
Sort By:
Journal of Reproductive Immunology|October 22, 2013
Characterisation of macaque testicular leucocyte populations and T-lymphocyte immunityRobert De Rose, Caroline S Fernandez, Mark P Hedger, et al.
Clinical & Translational Immunology|February 1, 2024
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expressionKirsty R Field, Kathleen M Wragg, Stephen J Kent, et al.
Frontiers in Immunology|January 13, 2018
Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 VaccinationSven Kratochvil, Paul F McKay, Amy W Chung, et al.
Journal of Virology|October 13, 2017
Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?Deborah Cromer, Mykola Pinkevych, Thomas A Rasmussen, et al.
Immunology and Cell Biology|October 23, 2021
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalenceHillary A Vanderven, Robyn Esterbauer, Sinthujan Jegaskanda, et al.
Journal of Virology|October 17, 2014
Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsShayarana L Gooneratne, Jonathan Richard, Wen Shi Lee, et al.
Frontiers in Immunology|March 7, 2018
Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 VaccinationSven Kratochvil, Paul F McKay, Amy W Chung, et al.
Biomaterials|June 24, 2009
A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsulesSiow-Feng Chong, Amy Sexton, Robert De Rose, et al.
Nature Medicine|March 2, 2023
Predicting the efficacy of variant-modified COVID-19 vaccine boostersDavid S Khoury, Steffen S Docken, Kanta Subbarao, et al.
Frontiers in Immunology|December 6, 2021
Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121Wen Shi Lee, Arnold Reynaldi, Thakshila Amarasena, et al.
Pageof 39

Showing results (91-100 of 390) with videos related to

Sort By:
Pageof 39
Journal of Reproductive Immunology|October 22, 2013
Characterisation of macaque testicular leucocyte populations and T-lymphocyte immunityRobert De Rose, Caroline S Fernandez, Mark P Hedger, et al.
Clinical & Translational Immunology|February 1, 2024
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expressionKirsty R Field, Kathleen M Wragg, Stephen J Kent, et al.
Frontiers in Immunology|January 13, 2018
Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 VaccinationSven Kratochvil, Paul F McKay, Amy W Chung, et al.
Journal of Virology|October 13, 2017
Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission?Deborah Cromer, Mykola Pinkevych, Thomas A Rasmussen, et al.
Immunology and Cell Biology|October 23, 2021
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalenceHillary A Vanderven, Robyn Esterbauer, Sinthujan Jegaskanda, et al.
Journal of Virology|October 17, 2014
Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsShayarana L Gooneratne, Jonathan Richard, Wen Shi Lee, et al.
Frontiers in Immunology|March 7, 2018
Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 VaccinationSven Kratochvil, Paul F McKay, Amy W Chung, et al.
Biomaterials|June 24, 2009
A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsulesSiow-Feng Chong, Amy Sexton, Robert De Rose, et al.
Nature Medicine|March 2, 2023
Predicting the efficacy of variant-modified COVID-19 vaccine boostersDavid S Khoury, Steffen S Docken, Kanta Subbarao, et al.
Frontiers in Immunology|December 6, 2021
Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121Wen Shi Lee, Arnold Reynaldi, Thakshila Amarasena, et al.
Pageof 39